Lisinopril & Amlodipine Interaction

Lisinopril (an ACE inhibitor) and amlodipine (a calcium channel blocker) are frequently prescribed together for the management of hypertension. This combination is not only safe but is considered a preferred evidence-based strategy for patients whose blood pressure is not adequately controlled with a single agent.

The ACCOMPLISH trial demonstrated that the combination of an ACE inhibitor with amlodipine was superior to an ACE inhibitor with hydrochlorothiazide in reducing cardiovascular events. This pairing leverages complementary mechanisms of action to achieve additive blood pressure lowering.

Fixed-dose combination products containing both lisinopril and amlodipine are available, reflecting the widespread clinical acceptance of this combination.

Lisinopril and amlodipine lower blood pressure through distinct, complementary mechanisms. Lisinopril inhibits angiotensin-converting enzyme (ACE), reducing angiotensin II production, which decreases vasoconstriction and aldosterone secretion. Amlodipine blocks L-type calcium channels in vascular smooth muscle, causing vasodilation. The combination produces additive antihypertensive effects without significant pharmacokinetic interactions. Neither drug affects the metabolism or clearance of the other.

This interaction is clinically beneficial rather than harmful. The additive blood pressure-lowering effect is the intended therapeutic goal. The risk of excessive hypotension exists but is generally manageable with appropriate dose titration. The ACCOMPLISH trial (n=11,506) showed that benazepril/amlodipine reduced the primary composite endpoint of cardiovascular death, MI, stroke, hospitalization for angina, resuscitation after sudden cardiac death, and coronary revascularization by 19.6% compared to benazepril/hydrochlorothiazide.

Start with lower doses of each medication and titrate gradually. Patients should be advised to rise slowly from sitting or lying positions to minimize orthostatic hypotension. Take both medications consistently at the same time each day. No specific dose adjustments are needed based on the combination itself, though individual doses should be optimized based on blood pressure response.

Monitor blood pressure regularly, especially during initial combination therapy and dose adjustments. Check serum potassium and renal function (BUN, creatinine) periodically, as ACE inhibitors can cause hyperkalemia and affect renal function. Monitor for peripheral edema, which is a common side effect of amlodipine. Watch for signs of hypotension such as dizziness or lightheadedness.

If the combination does not achieve adequate blood pressure control, a thiazide diuretic such as hydrochlorothiazide may be added as a third agent. If ACE inhibitor-related cough occurs, lisinopril can be replaced with an ARB (e.g., losartan or valsartan). Other calcium channel blockers such as nifedipine ER may substitute for amlodipine if peripheral edema is intolerable.